Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.
02

Bausch + Lomb Announces Availability of Illuminated Directional Laser Probe

Patented Technology Combines Exceptional Illumination with Advanced Directional Capabilities

 

FOR RELEASE TUESDAY, AUGUST 2, 2016

 

BRIDGEWATER, NJ – Bausch + Lomb, a leading global eye health company, today announced the availability of the Illuminated Directional Laser Probe, which combines the exceptional light technology of the company’s Illuminated Laser Probe with the advanced fiber capabilities of its Directional Laser Probe.

 

"The Illuminated Directional Laser Probe is the first of many innovations to come from our near-term pipeline as a direct result of our significant investment in R&D dedicated specifically to retina,” said Andrew Chang, senior vice president and general manager, U.S. Surgical, Bausch + Lomb. “Through this continued commitment and the invaluable partnership of the retina community, we look forward to delivering many more new technologies that help expand the horizons of retinal surgery.”

 

Using patented moving tube technology, the Illuminated Directional Laser Probe adjusts from straight to a curve of 85 degrees. The directional actuation of the fiber allows surgeons to enter the eye in the straight position, reducing the risk of bumping the natural lens while providing the ability to work around the posterior pole when applying laser treatment. Surgeons can adjust from straight to the curved position using an ergonomically designed slide button, which in combination with the illumination technology allows them to perform their own scleral depression while reaching the extreme periphery. The product features a midfield illumination pattern and is compatible with most modern, ophthalmic light sources.

 

“Maintaining your illumination pattern from a distance during retinal surgery can be a challenge,” said Brandon G. Busbee, M.D., from Tennessee Retina in Nashville, TN. “The moving tube design and recessed nature of the illumination fiber on Bausch + Lomb’s Illuminated Directional Laser Probe allows you to do that without extending the laser fiber toward the retina.”

 

Surgeons will have the opportunity to try the Illuminated Directional Laser Probe at the Bausch + Lomb booth (#103) at the American Society of Retina Surgeons meeting, August 9-14, 2016, in San Francisco, CA.

 

About Bausch + Lomb Retina
In September 2015, Bausch + Lomb acquired Synergetics®, bringing together agile innovation and enhanced resources, as well as the expertise of two organizations dedicated to serving the ophthalmology community with cutting-edge innovation of the highest quality. Our fully-integrated product portfolio now includes vitrectomy solutions such as the Stellaris® PC vision enhancement system and VersaVIT, as well as instrumentation, laser probes and illumination, all developed with years of experience and the guidance of retinal surgeons worldwide. For more information, visit www.bauschretina.com.

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Its core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.

 

Stellaris, VersaVit, and Synergetics are trademarks of Bausch & Lomb Incorporated or its affiliates.
Any other product/brand names are trademarks of their respective owners.
© 2016 Bausch & Lomb Incorporated.
STL.0080.USA.16

 

# # #

News Media Contacts:
Kristy Marks
PR Product Manager, Bausch + Lomb
(585) 338-8095 or kristy.marks@bausch.com

Teresa Panas
BioComm Network, on behalf of Bausch + Lomb
(973) 809-8590 or tpanas@biocommnetwork.com

Michele Gray
BioComm Network, on behalf of Bausch + Lomb
(917) 449-9250 or michele_gray@me.com

Actions: E-mail | Permalink |